E. Renea Snyder
Opioid prescriptions and addiction have made headlines across the world for almost a decade. As policy makers, hospitals, physicians, prisons, pharmaceuticals, etc. dedicate efforts to reduce the death tolls, conduct opioid education, and create new medications to treat pain, there are still many barriers to accessing quality addictions treatment. One of the leading barriers to treatment is transportation and access to quality care. With the increase in telehealth and telemedicine models of care, it was pertinent that addiction medicine joins telehealth on the proper evidence-based platform. With the patent pending telehealth evidence-based addictions model; the platform offers three levels of care (Outpatient, Intensive Outpatient, and Partial Hospitalization), individual, group, and recovery sessions, in-home services, 24/7 treatment access, and medication assisted treatment.
This is the first documented telehealth model of addictions treatment. The telehealth model meets some of the most restrictive state regulations, confidentiality requirements, highly trained/qualified clinicians, and documentation for addictions treatment.